Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients with Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial
Kazuma Oyama, Itamar Raz, Avivit Cahn, Erica L. Goodrich, Deepak L. Bhatt, Lawrence A. Leiter, Darren K. McGuire, John P.H. Wilding, Ingrid A.M. Gause-Nilsson, Ofri Mosenzon, Marc S. Sabatine, Stephen D. Wiviott
Dive into the research topics of 'Efficacy and Safety of Dapagliflozin According to Background Use of Cardiovascular Medications in Patients with Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial'. Together they form a unique fingerprint.